Extremity Medical Enters Closes Growth Financings

December 2023 – England & Company is pleased to announce it served as the exclusive placement agent on an $18 million in convertible notes issuance by Extremity Medical. Extremity Medical will use the new capital provided by its latest financing to invest in the growth of its business and refinance existing debt.

Extremity Medical’s innovative product portfolio includes advanced implant systems for addressing Charcot neuropathy in diabetic patients, as well as less-invasive surgical implants to correct common foot deformities, and address trauma and arthritis. Extremity Medical also offers a revolutionary total wrist replacement to restore more natural wrist motion in arthritic patients.